Abstract: A method comprising a series of selective extraction techniques for the parallel production of biodiesel and isolation of several valuable co-products including an alkenone hydrocarbon mixture of the kerosene/jet fuel range (primarily C10-, C12-, and C17-hydrocarbons) and fucoxanthin, a high-valued carotenoid, from the marine alkenone-producing microalgae Isochrysis.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: A method comprising a series of selective extraction techniques for the parallel production of biodiesel and isolation of several valuable co-products including an alkenone hydrocarbon mixture of the kerosene/jet fuel range (primarily C10-, C12-, and C17-hydrocarbons) and fucoxanthin, a high-valued carotenoid, from the marine alkenone-producing microalgae Isochrysis.

Abstract: Methods for treating a subject infected with Clostridium difficile comprises administering to the subject a synergistic combination of clofazimine and metronidazole. Pharmaceutical compositions comprising clofazimine and metronidazole are provided for treating Clostridium difficile infection and diseases or symptoms associated therewith.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: In certain aspects, the disclosure provides methods for producing polymers from alkenone-producing algae, such as algae species of the Isochrysis family.

Abstract: Methods for treating a subject infected with Clostridium difficile comprises administering to the subject a synergistic combination of clofazimine and metronidazole. Pharmaceutical compositions comprising clofazimine and metronidazole are provided for treating Clostridium difficile infection and diseases or symptoms associated therewith.

Abstract: A method for rotating macro-blocks of a frame of a video stream. A degree of rotation for the video stream is accessed. A macro-block of the video stream is accessed. The macro-block is rotated according to the degree of rotation. The macro-block is repositioned to a new position within the frame, wherein the new position is based on the degree of rotation.

Abstract: A video decoder architecture for processing out-of-order macro-blocks of a video stream. A microcode engine receives compressed data representing macro-blocks of a frame of a video stream, wherein at least one macro-block is received out-of-order. The microcode engine is for buffering the compressed data and for ordering the macro-blocks of the frame in raster scan order. A digital video decoder receives the macro-blocks in raster scan order and is for decoding the macro-blocks.

Abstract: A method for rotating macro-blocks of a frame of a video stream. A degree of rotation for the video stream is accessed. A macro-block of the video stream is accessed. The macro-block is rotated according to the degree of rotation. The macro-block is repositioned to a new position within the frame, wherein the new position is based on the degree of rotation.

Abstract: Methods for treating a subject infected with Clostridium difficile comprises administering to the subject a synergistic combination of clofazimine and metronidazole. Pharmaceutical compositions comprising clofazimine and metronidazole are provided for treating Clostridium difficile infection and diseases or symptoms associated therewith.

Abstract: According to an aspect of an embodiment, a method of providing a virtual class includes providing access to temporally-dimensioned educational material to participants of the virtual class in a social network. The method may also include capturing supplemental material generated by the participants interacting with each other in real-time in the social network. The method may also include associating the supplemental material with a range of relative time within the temporally-dimensioned educational material. The method may also include providing the temporally-dimensioned educational material to a client device associated with a participant of the virtual class. The method may also include providing the supplemental material to the client device for presentation at the client device during the range of relative time within the temporally-dimensioned educational material.

Abstract: For encoding, a frame of video data can be segregated into macroblocks, which can be segregated into slices, which in turn can be segregated into slice groups. A macroblock identifier (ID) can be associated with each of the macroblocks. When at least one slice from each of the slice groups has been encoded, the macroblock IDs associated with the encoded slices can be compared to determine an order in which the encoded slices are to be placed in an access unit for the frame. Of the encoded slices, the slice that includes the macroblock with the lowest macroblock ID will be placed in the access unit before the other encoded slices.

Abstract: The present disclosure provides a recombinant viral vector comprising at least one transgene inserted into a Marek's disease viral genome for treatment of diseases in poultry. Also provided are immunogenic compositions comprising such recombinant viral vectors and methods for preventing or inhibiting Marek's disease in combination with at least a second disease in poultry.

Abstract: A method for rotating macro-blocks of a frame of a video stream. A degree of rotation for the video stream is accessed. A macro-block of the video stream is accessed. The macro-block is rotated according to the degree of rotation. The macro-block is repositioned to a new position within the frame, wherein the new position is based on the degree of rotation.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: A graph database is described. The graph database includes one or more symbolic data stores and one or more key-value data stores. Each symbolic data store is configured to symbolically store sets of multiple hyper-graph nodes. Each key-value data store is configured to store attribute information for hyper-graph nodes and hyper-graph edges.

Abstract: The present invention relates to the formation and processing of nanostructures including nanotubes. Some embodiments provide processes for nanostructure growth using relatively mild conditions (e.g., low temperatures). In some cases, methods of the invention may improve the efficiency (e.g., catalyst efficiency) of nanostructure formation and may reduce the production of undesired byproducts during nanostructure formation, including volatile organic compounds and/or polycylic aromatic hydrocarbons. Such methods can both reduce the costs associated with nanostructure formation, as well as reduce the harmful effects of nanostructure fabrication on environmental and public health and safety.

Abstract: Methods for treating a subject infected with Clostridium difficile comprises administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of clofazimine and/or a clofazimine analogue. Pharmaceutical compositions comprising clofazimine and/or an analogue(s) thereof, and optionally one or more additional therapeutic agents, are provided for treating Clostridium difficile infection and diseases or symptoms associated therewith.